________________________________________________________
____Explicit____
217..228
1,0
#### Text ####
In addition
##############
#### Features ####
Wr, Comm, Null, Null
in addition, Expansion.Conjunction
____Arg1____
9..213
0
#### Text ####
Delmed Inc. 's top two officers resigned and were succeeded by executives of Fresenius USA Inc. and its parent, Fresenius AG, a major Delmed holder that has been negotiating to acquire a controlling stake
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
319..421
1,3,1
#### Text ####
negotiations about pricing had collapsed between it and a major distributor, National Medical Care Inc
##############
#### Features ####
Ot, Comm, Null, Null
314..318
1,2,1;1,2,3;1,3,0
#### Text ####
said
##############
________________________________________________________
________________________________________________________
____Implicit____
508
3
#### Features ####
Ot, Comm, Null, Null
425..436
2,0;2,1,0;2,2
#### Text ####
Delmed said
##############
although, Comparison.Concession.Contra-expectation
____Arg1____
437..506
2,1,1
#### Text ####
Robert S. Ehrlich resigned as chairman, president and chief executive
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
508..564
3
#### Text ####
Mr. Ehrlich will continue as a director and a consultant
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
638..642
4,0,1
#### Text ####
also
##############
#### Features ####
Wr, Comm, Null, Null
also, Expansion.Conjunction
____Arg1____
437..506
2,1,1
#### Text ####
Robert S. Ehrlich resigned as chairman, president and chief executive
##############
#### Features ####
Ot, Comm, Null, Null
425..436
2,0;2,1,0;2,2
#### Text ####
Delmed said
##############
____Arg2____
566..636;643..651
4,0,0;4,0,2
#### Text ####
Leslie I. Shapiro, chief operating officer and chief financial officer resigned
##############
#### Features ####
Ot, Comm, Null, Null
653..669
4,1;4,2;4,3;4,4
#### Text ####
the company said
##############
________________________________________________________
________________________________________________________
____Implicit____
789
6
#### Features ####
Wr, Comm, Null, Null
and, Expansion.Conjunction
____Arg1____
673..787
5
#### Text ####
Mr. Ehrlich was succeeded as chairman by Gerd Krick, a director of Fresenius, a West German pharmaceutical concern
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
789..892
6
#### Text ####
Ben Lipps, president of Fresenius USA, was named president, chief executive and chief operating officer
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
1101
10
#### Features ####
Wr, Comm, Null, Null
in addition, Expansion.Conjunction
____Arg1____
1036..1099
9
#### Text ####
Fresenius owns about 42% of Delmed's fully diluted common stock
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1101..1303
10
#### Text ####
The two companies have been discussing a transaction under which Fresenius would buy Delmed stock for cash to bring its beneficial ownership to between 70% and 80% of Delmed's fully diluted common stock
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
1321..1325
11,1
#### Text ####
also
##############
#### Features ####
Wr, Comm, Null, Null
also, Expansion.Conjunction
____Arg1____
1154..1303
10,1,1,1,1,1
#### Text ####
under which Fresenius would buy Delmed stock for cash to bring its beneficial ownership to between 70% and 80% of Delmed's fully diluted common stock
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1305..1320;1326..1364
11,0;11,2;11,3
#### Text ####
The transaction would combine Fresenius USA and Delmed
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
1690
14
#### Features ####
Ot, Comm, Null, Null
1681..1689
14,0;14,1,0;14,2;14,3
#### Text ####
It added
##############
however, Comparison.Concession.Contra-expectation
____Arg1____
1602..1678
13,3,1
#### Text ####
it "continues to explore the possibility of a combination with Fresenius USA
##############
#### Features ####
Ot, Comm, Null, Null
1579..1601
13,0;13,1;13,2;13,3,0;13,4;13,5
#### Text ####
Yesterday, Delmed said
##############
____Arg2____
1690..1812
14,1,1
#### Text ####
that it is apparent that any terms of a combination "would be substantially less favorable than those previously announced
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
1817..1822
15,0,0,0
#### Text ####
While
##############
#### Features ####
Wr, Comm, Null, Null
while, Comparison.Concession.Expectation
____Arg1____
1904..2028
15,0,1;15,0,2;15,0,3
#### Text ####
Delmed will continue to supply dialysis products through National Medical after their exclusive agreement ends in March 1990
##############
#### Features ####
Ot, Comm, Null, Null
2030..2041
15,1;15,2;15,3;15,4
#### Text ####
Delmed said
##############
____Arg2____
1823..1902
15,0,0,1
#### Text ####
the discussions between Delmed and National Medical Care have been discontinued
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
1978..1983
15,0,3,1,2,0
#### Text ####
after
##############
#### Features ####
Ot, Comm, Null, Null
2030..2041
15,1;15,2;15,3;15,4
#### Text ####
Delmed said
##############
after, Temporal.Asynchronous.Succession
____Arg1____
1904..1977
15,0,1;15,0,2;15,0,3,0;15,0,3,1,0;15,0,3,1,1
#### Text ####
Delmed will continue to supply dialysis products through National Medical
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1984..2028
15,0,3,1,2,1
#### Text ####
their exclusive agreement ends in March 1990
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
2043..2054
16,0,0
#### Text ####
In addition
##############
#### Features ####
Wr, Comm, Null, Null
in addition, Expansion.Conjunction
____Arg1____
1817..2028
15,0
#### Text ####
While the discussions between Delmed and National Medical Care have been discontinued, Delmed will continue to supply dialysis products through National Medical after their exclusive agreement ends in March 1990
##############
#### Features ####
Ot, Comm, Null, Null
2030..2041
15,1;15,2;15,3;15,4
#### Text ####
Delmed said
##############
____Arg2____
2056..2120
16,0,1;16,0,2;16,0,3
#### Text ####
Delmed is exploring distribution arrangements with Fresenius USA
##############
#### Features ####
Ot, Comm, Null, Null
2122..2133
16,1;16,2;16,3;16,4
#### Text ####
Delmed said
##############
________________________________________________________
